SIRC 26
Indian
India recorded over 15 lakh cancer cases in 2024: Govt
``The incidence of cancer is rising steadily in the country – from...
Sebi chief urges redefining role of independent directors as stewards of accountability
Role of independent directors requires a change in multiple areas....
Navi Technologies changes its name to Navi Limited
Navi Technologies Limited, promoter of Navi General Insurance, on...
India data breach costs reach new record level Of Rs 22 crores: IBM Report
“India's accelerating AI adoption brings immense opportunity, but...
International
Agile launches New Zealand operation to support Lloyd’s syndicate
The establishment of a New Zealand entity solidifies Agile’s...
Sunk superyacht likely to cost insurers at least $150 million, experts say
The hull was likely insured for around $40 million, while the...
Mpox emergency may add to economic, fiscal challenges in some African sovereigns: Fitch
In most of African countries , the number of confirmed mpox cases...
GIC Re emerges as the 10th largest global reinsurer in AM Best’s latest chart
In AM Best's `World’s 50 largest reinsurers in 2023’, Munich Re is...
Briefs
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Events
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Articles
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Features
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Data
Interviews
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Facts
Britain moves closer to COVID-19 vaccine trials that infect volunteers
LONDON:- “Human challenge” trials of potential COVID-19 vaccines, where volunteers are deliberately infected with the disease, could become a reality after a British biotech firm signed a contract with the government to create and provide strains of...
Coronavirus vaccine candidate from China’s CNBG shows promise in human test, study shows
BEIJING: One of China’s front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early and mid-stage test in humans, researchers said. The potential vaccine, dubbed BBIBP-CorV, is being developed by...
91 million urban Indians lack basic handwashing facilities at home: UNICEF
New Delhi: Around 91 million urban Indians lack basic handwashing facilities at home, UNICEF has said while noting that washing of hands with soap is critical in the fight against infectious diseases like COVID-19. In a statement released on the occasion on...
Oxford scientists develop five-minute COVID-19 antigen test
LONDON: Scientists from Britain’s University of Oxford have developed a rapid COVID-19 test able to identify the coronavirus in less than five minutes, researchers said on Thursday, adding it could be used in mass testing at airports and businesses. The...
WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patients
Gilead Sciences Inc’s remdesivir had little or no effect on COVID-19 patients’ length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.The antiviral medication, among the first to be used as a...